Document is current
Any future updates will be listed below
-
Authors
Ovsepian, Saak V. https://orcid.org/0000-0002-9522-4159
Waxman, Stephen G. https://orcid.org/0000-0001-5718-7177
- License Information
-
More Information
Article History
Accepted: 22 December 2022
First Online: 19 January 2023
Competing interests
: During the past twelve months, S.G.W. has served on the scientific advisory boards of OliPass Corp., Navega Therapeutics and Medtronic, and has served as an adviser to Sangamo Therapeutics, Exicure, Alnylam Pharmaceuticals, Chromocell, Ionis Pharmaceuticals and Replay Therapeutics.
